drugset / Trial / NCT00742573

Incorporating Patient Treatment Choice to Improve Treatment Retention in Depressed Hispanics

NCT00742573 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

This study will determine whether combination treatment driven by patient choice is better than standardized medication treatment at retaining and improving Hispanic patients with major depressive disorder.

Timeline

Start
2008-08
Primary completion
2014-01-10
Completion
2014-01-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule — —
Subject Citalopram Small molecule — —
Subject Duloxetine Small molecule — —
Subject Escitalopram Small molecule — —
Subject Mirtazapine Other / unclassified — —
Subject Nortriptyline Small molecule — —
Subject Paroxetine Small molecule — —
Subject Sertraline Small molecule — —
Subject Venlafaxine Small molecule — —